Search Results

There are 37609 results for: content related to: Maintenance therapy with bacillus Calmette-Guérin Connaught strain clearly prolongs recurrence-free survival following transurethral resection of bladder tumour for non-muscle-invasive bladder cancer

  1. Intravesical Bacillus Calmette-Guérin with interferon-alpha versus intravesical Bacillus Calmette-Guérin for treating non-muscle-invasive bladder cancer

    Intervention Review

    The Cochrane Library

    Andrew RH Shepherd, Emily Shepherd and Nicholas R Brook

    Published Online : 8 MAR 2017, DOI: 10.1002/14651858.CD012112.pub2

  2. Intravesical Bacillus Calmette-Guérin versus epirubicin for Ta and T1 bladder cancer

    Intervention Review

    The Cochrane Library

    Pan Feng Shang, Joey Kwong, Zhi Ping Wang, Jinhui Tian, Lei Jiang, KeHu Yang, Zhong Jin Yue and Jun Qiang Tian

    Published Online : 11 MAY 2011, DOI: 10.1002/14651858.CD006885.pub2

  3. Non-muscle invasive bladder cancer and bacillus Calmette-Guerin treatment: a review of the literature

    International Journal of Urological Nursing

    Volume 9, Issue 2, July 2015, Pages: 57–68, Jason Alcorn, Rob L Burton and Annie Topping

    Version of Record online : 14 OCT 2014, DOI: 10.1111/ijun.12055

  4. You have free access to this content
    Interleukin-10 inhibits Mycobacterium bovis bacillus Calmette–Guérin (BCG)-induced macrophage cytotoxicity against bladder cancer cells

    Clinical & Experimental Immunology

    Volume 160, Issue 3, June 2010, Pages: 359–368, Y. Luo, R. Han, D. P. Evanoff and X. Chen

    Version of Record online : 10 FEB 2010, DOI: 10.1111/j.1365-2249.2010.04105.x

  5. You have free access to this content
    Recombinant Mycobacterium bovis bacillus Calmette-Guérin (BCG) expressing mouse IL-18 augments Th1 immunity and macrophage cytotoxicity

    Clinical & Experimental Immunology

    Volume 137, Issue 1, July 2004, Pages: 24–34, Y. LUO, H. YAMADA, X. CHEN, A. A. RYAN, D. P. EVANOFF, J. A. TRICCAS and M. A. O'DONNELL

    Version of Record online : 10 JUN 2004, DOI: 10.1111/j.1365-2249.2004.02522.x

  6. Non–muscle-invasive bladder cancer: Intravesical treatments beyond Bacille Calmette-Guérin

    Cancer

    Volume 123, Issue 3, February 1, 2017, Pages: 390–400, Vignesh T. Packiam, Scott C. Johnson and Gary D. Steinberg

    Version of Record online : 2 NOV 2016, DOI: 10.1002/cncr.30392

  7. You have free access to this content
    Prophylactic Treatment of Superficial Bladder Tumor

    International Journal of Urology

    Volume 5, Issue 6, November 1998, Pages: 511–520, Chongwook Lee and Moon Soo Park

    Version of Record online : 2 JUL 2007, DOI: 10.1111/j.1442-2042.1998.tb00404.x

  8. You have free access to this content
    Bacillus Calmette–Guérin treatment of non-muscle invasive bladder cancer

    International Journal of Urology

    Volume 18, Issue 2, February 2011, Pages: 113–120, Richard J Sylvester

    Version of Record online : 22 NOV 2010, DOI: 10.1111/j.1442-2042.2010.02678.x

  9. You have free access to this content
    Bacillus calmette—Guérin treatment of existing papillary bladder cancer and carcinoma in situ of the bladder. Four-year results

    Cancer

    Volume 75, Issue 2, 15 January 1995, Pages: 552–559, Hideyuki Akaza, Shiro Hinotsu, Yoshio Aso, Tadao Kakizoe and Bladder Cancer BCG Study Group

    Version of Record online : 28 JUN 2006, DOI: 10.1002/1097-0142(19950115)75:2<552::AID-CNCR2820750219>3.0.CO;2-H

  10. You have full text access to this Open Access content
    Bacillus Calmette–Guerin (BCG) immunotherapy for bladder cancer: Current understanding and perspectives on engineered BCG vaccine

    Cancer Science

    Volume 104, Issue 1, January 2013, Pages: 22–27, Koji Kawai, Jun Miyazaki, Akira Joraku, Hiroyuki Nishiyama and Hideyuki Akaza

    Version of Record online : 3 JAN 2013, DOI: 10.1111/cas.12075

  11. Intravesical Bacillus Calmette-Guérin with the Danish Strain for Treatment of Carcinoma In situ of the Bladder

    British Journal of Urology

    Volume 72, Issue 5, November 1993, Pages: 744–748, H. OVESEN, A. L. POULSEN and K. STEVEN

    Version of Record online : 26 NOV 2008, DOI: 10.1111/j.1464-410X.1993.tb16260.x

  12. Intravesical electromotive drug administration for non-muscle invasive bladder cancer

    Intervention Review

    The Cochrane Library

    Jae Hung Jung, Ahmet Gudeloglu, Halil Kiziloz, Gretchen M Kuntz, Alea Miller, Badrinath R Konety and Philipp Dahm

    Published Online : 12 SEP 2017, DOI: 10.1002/14651858.CD011864.pub2

  13. You have free access to this content
    Intravesical 4′-epi-doxorubicin(epirubicin) versus bacillus calmette—guérin. A controlled prospective study on the prophylaxis of superficial bladder cancer

    Cancer

    Volume 72, Issue 5, 1 September 1993, Pages: 1749–1755, Michael D. Melekos, Heracles S. Chionis, George S. Paranychianakis and Houssam H. Dauaher

    Version of Record online : 28 JUN 2006, DOI: 10.1002/1097-0142(19930901)72:5<1749::AID-CNCR2820720539>3.0.CO;2-8

  14. You have free access to this content
    BCG treatment for bladder cancer, from past to present use

    International Journal of Urological Nursing

    Volume 9, Issue 3, November 2015, Pages: 177–186, Jason Alcorn, Rob Burton and Annie Topping

    Version of Record online : 26 DEC 2014, DOI: 10.1111/ijun.12064

  15. You have free access to this content
    Interleukin 10 induced augmentation of delayed-type hypersensitivity (DTH) enhances Mycobacterium bovis bacillus Calmette-Guérin (BCG) mediated antitumour activity

    Clinical & Experimental Immunology

    Volume 131, Issue 2, February 2003, Pages: 206–216, R. NADLER, Y. LUO, W. ZHAO, J. K. RITCHEY, J. C. AUSTIN, M. B. COHEN, M. A. O'DONNELL and T. L. RATLIFF

    Version of Record online : 31 JAN 2003, DOI: 10.1046/j.1365-2249.2003.02071.x

  16. Insignificant role of bacillus Calmette–Guérin maintenance therapy after complete transurethral resection of bladder tumor for intermediate- and high-risk non-muscle-invasive bladder cancer: Results from a randomized trial

    International Journal of Urology

    Volume 23, Issue 10, October 2016, Pages: 854–860, Yasushi Nakai, Satoshi Anai, Nobumichi Tanaka, Yoshitomo Chihara, Masaki Haramoto, Takeshi Otani, Yoshinori Nakagawa, Yoshihiko Hirao, Noboru Konishi and Kiyohide Fujimoto

    Version of Record online : 15 JUL 2016, DOI: 10.1111/iju.13167

  17. Analysis of early failures after intravesical instillation therapy with bacille Calmette-Guerin for carcinoma in situ of the bladder

    British Journal of Urology

    Volume 75, Issue 2, February 1995, Pages: 180–184, V.W. Merz, D. Marth, R. Kraft, D.K. Ackermann, E.J. Zingg and U.E. Studer

    Version of Record online : 21 NOV 2008, DOI: 10.1111/j.1464-410X.1995.tb07307.x

  18. Intravesical Bacillus Calmette-Guérin in Ta and T1 bladder cancer

    Intervention Review

    The Cochrane Library

    Mike Shelley, J B Court, H Kynaston, Timothy J Wilt, Reg Fish and Malcolm Mason

    Published Online : 23 OCT 2000, DOI: 10.1002/14651858.CD001986

  19. You have free access to this content
    Bacille Calmette-Guérin in superficial transitional cell carcinoma

    British Journal of Urology

    Volume 82, Issue 2, August 1998, Pages: 213–223, Mungan and Witjes

    Version of Record online : 4 JAN 2002, DOI: 10.1046/j.1464-410X.1998.00720.x